beta-naphthoflavone has been researched along with Prostatic Hyperplasia in 1 studies
beta-Naphthoflavone: A polyaromatic hydrocarbon inducer of P4501A1 and P4501A2 cytochromes. (Proc Soc Exp Biol Med 1994 Dec:207(3):302-308)
beta-naphthoflavone : An extended flavonoid resulting from the formal fusion of a benzene ring with the f side of flavone.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gemzik, B | 1 |
| Jacob, S | 1 |
| Jennings, S | 1 |
| Veltman, J | 1 |
| Parkinson, A | 1 |
1 other study available for beta-naphthoflavone and Prostatic Hyperplasia
| Article | Year |
|---|---|
Species differences in 5 alpha-androstane-3 beta,17 beta-diol hydroxylation by rat, monkey, and human prostate microsomes.
Topics: Androstane-3,17-diol; Animals; Antibodies; Antifungal Agents; Benzoflavones; beta-Naphthoflavone; Ca | 1992 |